Phaseform will be represented in the ARVO 2024 Annual Meeting by it's CEO, Dr Stefan Weber. This ARVO event is the premier opportunity for professionals from vision and eye research to connect and exchange - this year set in the dynamic city of Seattle from May 5-9. ARVO ).
This year, we are highlighting a significant advancement in retinal imaging through the retrofit of our Deformable Phase Plate (DPP) technology into existing Full-Field OCT systems. This enhancement has been implemented at the Quinze-Vingt Hospital in Paris, in collaboration with researchers from Institut Langevin, Institut de la Vision, and the company SharpEye.
The retrofit involves integrating our DPP technology directly with traditional OCT systems, enhancing their capabilities to correct for high-order aberrations dynamically. This integration allows for superior imaging quality, achieving cellular resolution that is critical for precise diagnostic and therapeutic applications.
Session details: Our breakthroughs will be on display at the session scheduled for Tuesday, May 7, from 1:15 PM to 3:00 PM at poster board number A0309.
We look forward to sharing how Phaseform’s technology can enable setting new standards in retinal imaging, and discussing future applications with fellow researchers and clinicians at ARVO 2024!
Links:
